Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of INFINITY PHARMA is 0.3% (very low). The company has been active since 1976 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Trust signals
2 signalsAdministrative Flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
Annual accounts & ratios
Source: NBB| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 11-06-2026 | 2026-00157374 |
| 31-12-2024 | volledig | 15-09-2025 | 2025-00493685 |
| 31-12-2023 | volledig | 07-06-2024 | 2024-00119284 |
| 31-12-2022 | volledig | 05-06-2023 | 2023-00109744 |
| 31-12-2021 | volledig | 31-05-2022 | 2022-20042942 |
| 31-12-2020 | volledig | 25-05-2021 | 2021-15200233 |
| 31-12-2019 | volledig | 31-05-2020 | 2020-13900411 |
| 31-12-2018 | volledig | 23-05-2019 | 2019-14100048 |
| 31-12-2017 | volledig | 23-05-2018 | 2018-13500082 |
| 31-12-2016 | volledig | 09-05-2017 | 2017-11500389 |
Directors
Directors & mandates
20 directors-
Current10-05-2022 → present
-
Current01-04-2021 → present
-
Current04-12-2017 → present
2 events
- 09-05-2023 Mandate renewed· Director
- 04-12-2017 Appointed· Director
-
Current01-07-2016 → present
2 events
- 12-05-2021 Appointed· Director
- 01-07-2016 Appointed· Director
Historic, not recently confirmed (4)
-
Not recently confirmedlast confirmed in an act from 2018
2 events
- 08-02-2018 Appointed· Managing director
- 17-10-2016 Appointed· Director
-
Jumoo bvbaLegal entityDaily management· perm. rep.: Daan VermeuienState Gazette act 17140134 (04-10-2017)Not recently confirmedlast confirmed in an act from 2017
-
BVBA ROMANI MANAGEMENTLegal entityDirector· perm. rep.: Filip HoornaertState Gazette act 14051368 (26-02-2014)Not recently confirmedlast confirmed in an act from 2014
-
Not recently confirmedlast confirmed in an act from 2014
2 events
- 14-05-2013 Mandate renewed· Director
- 14-05-2013 Appointed· Managing director
Former directors (12)
-
Former01-07-2016 → 01-04-2026
3 events
- 01-04-2026 Resigned· Director
- 12-05-2021 Appointed· Director
- 01-07-2016 Appointed· Director
-
Former01-09-2019 → 01-04-2021
2 events
- 01-04-2021 Resigned· Director
- 01-09-2019 Appointed· Director
-
Former01-10-2020 → 01-03-2021
2 events
- 01-03-2021 Resigned· Director
- 01-10-2020 Appointed· Managing director
-
Former12-12-2015 → 04-12-2017
3 events
- 04-12-2017 Resigned· Director
- 12-12-2015 Appointed· Director
- 12-12-2015 Appointed· Managing director
-
Former01-04-2017 → 01-09-2017
2 events
- 01-09-2017 Resigned· Daily management
- 01-04-2017 Appointed· Daily management
-
Former01-04-2017 → 01-06-2017
2 events
- 01-06-2017 Resigned· Daily management
- 01-04-2017 Appointed· Daily management
-
Former17-10-2016 → 01-04-2017
2 events
- 01-04-2017 Resigned· Daily management
- 17-10-2016 Appointed· Managing director
-
Procuram bvbaLegal entityDaily management· perm. rep.: Michaël HillaertState Gazette act 17076800 (31-05-2017)Former- → 01-04-2017
-
Former17-10-2016 → 01-04-2017
2 events
- 01-04-2017 Resigned· Daily management
- 17-10-2016 Appointed· Managing director
-
Jan Peeters NVLegal entityDirector· perm. rep.: Jan PeetersState Gazette act 16173895 (20-12-2016)Former- → 17-10-2016
-
Former01-01-2014 → 17-10-2016
2 events
- 17-10-2016 Resigned· Managing director
- 01-01-2014 Appointed· Director
-
Former14-05-2013 → 12-12-2015
3 events
- 12-12-2015 Resigned· Director
- 12-12-2015 Resigned· Managing director
- 14-05-2013 Appointed· Director
Statutory auditor
3 auditors| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| PricewaterhouseCoopers Reviseurs d'EntreprisesCurrent Statutory auditor · represented by Lien Winne |
- | 31-12-2025 → present |
| Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises Statutory auditor · represented by Ine Nuyts succeeded by PricewaterhouseCoopers Reviseurs d'Entreprises in 2025 |
- | 16-10-2019 → 31-12-2025 |
| PWC Bedrijfsrevisoren BCVBA Company auditor · represented by Peter Van den Eynde succeeded by Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises in 2019 |
- | 06-02-2014 → 16-10-2019 |
Insolvency mandates
Legal Structure
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 08-12-1976 |
| Status | Active |
| Postal code | 9810 |
Structure & network
Connections & network
13 connected companiesLocations & real estate
Establishment units
1 locationReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44048A0094/00L000 | Flanders | 1.6 ha | 1 · 7,284 m² | 21.6 m · 2 fl. |
Publications
Lifecycle & Insolvency Signals
Belgian State Gazette · acts
55 verified actsWhat every Belgian State Gazette publication actually says, each act broken down into appointments, capital movements, seat moves and statute amendments.
- General meeting , 29/06/2026
- Name change , Infinity Pharma
- Statutes amendment
- Director resignation, VERLINDEN Johan (bestuurder)
- Power of attorney, bestuursorgaan, notaris/RVH-Notarissen, bedienden/aangestelden/lasthebbers
- General meeting , 16-12-2025
- Capital increase , €4.000.000
- Bank account , 15-12-2025
- Capital , €13.300.000
- Power of attorney, Stijn RAES
- Power of attorney, het bestuursorgaan
- General meeting , 06/10/2025
- Auditor appointment, PwC Bedrijfsrevisoren BV (commissaris)
- Permanent representative, Lien Winne (vaste vertegenwoordiger)
- Mandate compensation, PwC Bedrijfsrevisoren BV
- General meeting , 20/12/2024
- Capital increase , €15.009.359,36
- Bank account , 20/12/2024
- Capital decrease , €7.368.329,98
- Capital , €9.300.000
- Power of attorney, Franck Cléty
- General meeting , 09/05/2023
- Director reappointment, Padilla Rafael (bestuurder)
- General meeting , 21/06/2023
- Merger , 21/06/2023
- Name change , PHARMA-PACK
- Power of attorney, CLETY Franck
- Power of attorney, William VAN LANCKER
- Board meeting , 01/04/2023
- Merger
- Power of attorney, William Van Lancker
- Power of attorney, Franck Cléty
- Corporate purpose , De vennootschap heeft tot voorwerp: De studie, het onderzoek, het ontwerp, de analyse, de beschouwing, de farmacodynamie, de productie, de vervaardiging, de pro…
- Corporate purpose , De vennootschap heeft als doel: productie, aan- en verkoop, in- en uitvoer, groot- en kleinhandel, verhuring, commissiehandel, vertegenwoordiging en consignatie…
- General meeting , 11/05/2021
- Director appointment, Johan Verlinden (bestuurder)
- Director appointment, Céline Caveye (bestuurder)
- Power of attorney, William Van Lancker
- General meeting , 10/05/2022
- Approval , jaarrekening afgesloten op 31 december 2021
- Director reappointment, De Jong Cormelia Neeltje (bestuurder)
- Auditor appointment, Deloitte Bedrijfsrevisoren CVBA (Commissaris)
- Director discharge, INFINITY PHARMA
- Director discharge, INFINITY PHARMA
- Merger , met fusie door overneming gelijkgestelde verrichting
- Name change , INFINITY PHARMA
- Statutes amendment
- Statutes amendment
- Capital , €1.658.970,62
- Corporate purpose , De studie, het onderzoek, het ontwerp, de analyse, de beschouwing, de farmacodynamie, de productie, de vervaardiging, de promotie, de verkoop, de handel, de ver…
- Director resignation, Hernando Acosta (persoon belast met het dagelijks bestuur)
- Director resignation, Bart Ameije (persoon belast met het dagelijks bestuur)
- Director discharge, Hernando Acosta
- Director discharge, Bart Ameije
- Director appointment, Peter De Sutter (persoon belast met het dagelijks bestuur)
- Board meeting , 01/04/2021
- Power of attorney, Tim Delameilleure
- Power of attorney, Franck Cléty
- Merger
- Accounting effect , 01/01/2021
- Corporate purpose , De vennootschap heeft tot doel: de studie, het onderzoek, het ontwerp, de analyse, de beschouwing, de farmacodynamie, de productie, de vervaardiging, de promoti…
Show 12 older acts
What every Belgian State Gazette publication actually says, each act broken down into appointments, capital movements, seat moves and statute amendments.
- Board meeting , 01/10/2020
- Director appointment, Hernando Acosta (persoon belast met het dagelijks bestuur)
- Merger
- Net-asset statement , 31/12/2019
- Board meeting , 28 mei 2020
- Merger
- Power of attorney, Tim Delameilleure
- Power of attorney, Franck Cléty
- Accounting effect , 1 januari 2020
- Corporate purpose , De vennootschap heeft tot doel: de studie, het onderzoek, het ontwerp, de analyse, de beschouwing, de farmacodynamie, de productie, de vervaardiging, de promoti…
- Board meeting , 01/09/2019
- Director appointment, Bart Ameije (persoon belast met het dagelijks bestuur)
- General meeting , 24/06/2019
- Auditor appointment, Deloitte Bedrijfsrevisoren CVBA (Commissaris)
- Permanent representative, Ine Nuyts
- Board meeting , 25/03/2019
- Director resignation, Jumoo bvba (persoon belast met het dagelijks bestuur)
- Director discharge, Jumoo bvba
- Merger
- Merger
- Net-asset statement , 31/08/2018
- Power of attorney, Tim DELAMEILLEURE
- Power of attorney, Katja VAN DALSEN
- Board meeting , 06/09/2018
- Power of attorney, Tim Delameilleure
- Power of attorney, Katja van Dalsen
- Merger
- Accounting effect , 01/09/2018
- Corporate purpose , De vennootschap heeft tot doel: de studie, het onderzoek, het ontwerp, de analyse, de beschouwing, de farmacodynamie, de productie, de vervaardiging, de promoti…
- Merger
- Power of attorney, Tim Delameilleure
- Power of attorney, Katja van Dalsen
- Accounting effect , 01/09/2018
- Corporate purpose , De vennootschap heeft tot doel: de studie, het onderzoek, het ontwerp, de analyse, de beschouwing, de farmacodynamie, de productie, de vervaardiging, de promoti…
- Corporate purpose , De vennootschap heeft tot doel: 1.Het produceren en ontwikkelen van cosmetica, dieetproducten, farmaceutische, scheikundige, parafarmaceutische en homeopatische…
- General meeting , 11/06/2018
- Merger , absorption, 31/12/2017
- Capital increase , €99.873,22
- Capital increase , €859.098,16
- Statutes amendment
- Power of attorney, Tim DELAMEILLEURE
- Board meeting , 19/03/2018
- Merger
- Power of attorney, Tim Delameilleure
- Power of attorney, Katja van Dalsen
- Corporate purpose , De vennootschap heeft tot doel: De studie, het onderzoek, het ontwerp, de analyse, de beschouwing, de farmacodynamie, de productie, de vervaardiging, de promoti…
- Corporate purpose , De Vennootschap heeft tot doel, zowel in België als in het buitenland zowel voor eigen naam en voor eigen rekening als voor naam of voor rekening van derden, al…
- General meeting , 04/12/2017
- Board meeting , 04/12/2017
- Director resignation, Johannes Stols (bestuurder)
- Director discharge, Johannes Stols
- Director appointment, Rafael Padilla (bestuurder)
- Mandate compensation, Rafael Padilla
Analysis
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
AI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, nearest firstCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameNL | INFINITY PHARMA |
| Legal nameNL | PHARMA-PACK |